Back to search

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

Tetsuya Kubota, Kozo Koshizuka, Elizabeth A. Williamson, Hiroya Asou, Jonathan W. Said
PubMed

Data up to Jan 2025

Published1998
Citations599
References0
Fields
ChemistryBiologyMedicineEndocrinologyInternal medicineBiotechnology

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

No citing papers found in database

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent… (1998) – PubMed | Metascience Observatory Explorer